Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMOTE-Chemop: Malaria Chemoprevention in Ugandan Children
NCT00948896Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Jun 2010
- Primary completion
- Apr 2014
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dihydroartemisinin + piperaquine, sulfadoxine + pyrimethamine, trimethoprim + sulfamethoxazole in malaria, sponsored by University of California, San Francisco. Started Jun 2010; status: completed.
02
Drugs
dihydroartemisinin + piperaquinesulfadoxine + pyrimethaminetrimethoprim + sulfamethoxazole
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00948896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00948896.